Proposals of the Shareholders’ Nomination Board to Canatu’s Annual General Meeting

Canatu Plc Company release 19 March 2026 at 2:00 p.m. EET

Proposals of the Shareholders’ Nomination Board to Canatu’s Annual General Meeting

Canatu Oyj’s Shareholders’ Nomination Board (the “Nomination Board”) has submitted to the company’s Board of Directors its proposals to the 2026 Annual General Meeting.

Number of board members

The Nomination Board proposes that the number of members of the Board of Directors shall be seven.

Board members

In accordance with the company’s Articles of Association, Lifeline SPAC I’s sponsors have the right to appoint two Board members and the General Meeting therefore appoints the other five Board members. The company has received a notice from the sponsors, pursuant to which Timo Ahopelto and Tuomo Vähäpassi will continue as the sponsor representatives in the company’s Board of Directors. Timo Ahopelto and Tuomo Vähäpassi are appointed as members of the Board of Directors until the end of the next Annual General Meeting.

The Nomination Board proposes that of the current Board members Ari Ahola, Dino Nardicchio, Kai Seikku and Bernhard Stockmeyer are re-elected as members of the Board until the end of the next Annual General Meeting.

The Nomination Board further proposes that Anette Engelhardt is elected as a new member of the Board of Directors until the end of the next Annual General Meeting. A brief presentation of the proposed new member is attached to this release.

Of the Board nominees, Timo Ahopelto, Anette Engelhardt, Dino Nardicchio, Kai Seikku and Bernhard Stockmeyer are independent of the company and its major shareholders. Tuomo Vähäpassi is independent of the major shareholders of the company but not of the company. Ari Ahola is not independent of the company nor its major shareholders.

The Board nominees have given their consent to the election.

With regard to the selection procedure for the members of the Board of Directors, the Nomination Board recommends that shareholders take a position on the proposal as a whole at the Annual General Meeting.

Board remuneration

The Nomination Board proposes that the members of the Board of Directors be paid annual remuneration as follows:

• EUR 80,000 for the Chair of the Board; and
• EUR 60,000 for each ordinary member of the Board.

The annual remuneration will be paid to the Board members in proportion to the length of their term, so that for each month commencing until the next Annual General Meeting, an amount equal to the annual remuneration divided by twelve (12) shall accrue.

In addition, the Nomination Board proposes that the travel expenses of the Board members and other expenses directly related to their work be reimbursed in accordance with the company's current practice. Additionally, each Board member is proposed to receive a fee of EUR 3,000 for meetings held outside their continent of residence.

The Nomination Board’s composition

In accordance with its charter, Canatu’s Nomination Board consists of four members, representing Canatu’s four largest shareholders, who held the largest number of votes in Canatu based on the shareholders’ register as per the situation on the first banking day of October 2025, considering the nominee-registered shares, and exercised their right of appointment.

As of 7 January 2026, the Nomination Board that prepared the above proposals composed of Ari Ahola (eFruit International, Inc.) as the Chair as well as Shinichiro Nakamura (DENSO Corporation), Denis Cherkasov (Mymetics Holding (Cyprus) Limited) and Tuomo Vähäpassi (Inventure Fund Ky) as members. The Chair of Canatu’s Board of Directors participates in the Nomination Board’s work as an expert without having a right to participate in the decision-making.

The Nomination Board made the above proposals unanimously. The proposals will be included in the notice convening the Annual General Meeting to be published at a later date. Canatu’s Annual General Meeting is scheduled to be held on 16 April 2026.

Additional information

Juha Kokkonen, CEO, juha.kokkonen@canatu.com, +358 40 543 0367

Mari Makkonen, VP, IR, Communications & Marketing, mari.makkonen@canatu.com, +358 50 442 2343

Certified adviser

DNB Carnegie Investment Bank AB (publ), tel. +46 (0) 8 588 685 70

About Canatu

Canatu (CANATU, Nasdaq First North, Finland) is a fast-growing deep technology company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.

Canatu’s versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling more effective manufacturing of the most advanced chips, as well as film heaters for advanced driver-assistance systems (ADAS) in the automotive industry. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and Dry DepositionTM method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.

Headquartered in Finland, Canatu also operates in the US, Japan and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has 145 full-time equivalent employees representing over 35 nationalities, with nearly 20% holding or pursuing doctorates. Discover more at www.canatu.com and follow us on LinkedIn.